Table 1 |
||||||
|
Description of E. sakazakii and E. cloacae strains used in this study |
||||||
|
Organism |
Strain number |
Neonate |
Isolation site |
Symptoms |
Isolation date (day/mn/yr) |
PFGE profile |
|
|
||||||
|
E. sakazakii |
696 |
D |
Stools |
NEC IIb |
08/06/1994 |
1 |
|
E. sakazakii |
701 |
F |
Peritoneal fluid |
NEC IIIb (died) |
07/04/1994 |
2 |
|
E. sakazakii |
767a |
H |
Trachea |
Meningitis (died) |
11/05/1994 |
2 |
|
E. sakazakii |
709 |
C |
Trachea |
Septicaemia |
12/05/1994 |
2 |
|
E. sakazakii |
695a |
J |
Trachea |
NEC II (died) |
07/06/1994 |
2 |
|
E. sakazakii |
693 |
Q |
Stools |
Asymptomatic |
18/06/1994 |
3 |
|
E. sakazakii |
716 |
Infant formula |
11/07/1994 |
4 |
||
|
E. cloacae |
766 |
R |
Blood culture |
Sepsis (died) |
04/06/1994 |
NAc |
|
|
||||||
|
a Strains demonstrated extended spectrum β-lactamase activities. b NEC Stage II (definite NEC) is characterised by the systemic signs of temperature instability, apnoea, bradycardia, lethargy with additional symptoms of absence of bowel sounds, radiological signs of intestinal dilation, ileus and pneumatosis intestinalis. NEC Stage III (advanced NEC) is where the neonate is critically ill with metabolic acidosis, neutropenia, signs of generalised peritonitis, marked tenderness and distension of abdomen. c NA, Not appropriate |
||||||
|
Townsend et al. BMC Microbiology 2008 8:64 doi:10.1186/1471-2180-8-64 |
||||||